Clinical Study

Assessment of Insulin Resistance in Subjects with Normal Glucose Tolerance, Hyperinsulinemia with Normal Blood Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed Type 2 Diabetes (Prediabetes Insulin Resistance Research)

Table 6

Subgroup analyses according to BMI—mean ± SE ().

NGT ()HINS ()IGT ()T2DM ()
Nonobesity ()Overweight ()Obesity ()Nonobesity ()Overweight ()Obesity ()Nonobesity ()Overweight ()Obesity ()

Weight (Kg)62.20 ± 6.7563.38 ± 4.2376.04 ± 6.6491.50 ± 12.8063.50 ± 3.6372.63 ± 7.5691.50 ± 9.5762.43 ± 8.9471.38 ± 4.2590.42 ± 7.872
BMI (kg/m2)22.41 ± 1.5422.90 ± 0.6526.39 ± 0.8832.66 ± 1.5622.72 ± 0.58 25.98 ± 1.3931.32 ± 2.052.88 ± 0.8126.05 ± 1.2931.57 ± 2.29
Waist (cm)76.75 ± 7.7277.75 ± 9.1188.50 ± 6.76102.25 ± 7.3977.88 ± 6.4389.46 ± 5.5399.61 ± 7.7982.29 ± 5.0990.08 ± 4.40105.83 ± 6.05
TG (mmol/L)1.24 ± 0.732.13 ± 1.122.67 ± 1.642.14 ± 1.301.33 ± 0.811.88 ± 1.312.59 ± 0.901.31 ± 0.541.80 ± 0.812.26 ± 0.87
HDL (mmol/L)1.62 ± 0.351.36 ± 0.191.41 ± 0.381.35 ± 0.291.34 ± 0.181.32 ± 0.481.04 ± 0.231.20 ± 0.161.06 ± 0.200.88 ± 0.15
FINS (mU/L)5.29 ± 4.616.25 ± 1.6411.39 ± 5.9915.45 ± 5.827.20 ± 4.9410.16 ± 6.0416.21 ± 6.563.52 ± 0.889.91 ± 6.99612.701 ± 6.31
value
Matsuda index13.16 ± 7.246.28 ± 0.49 4.88 ± 2.264.12 ± 1.5010.92 ± 4.646.57 ± 2.974.11 ± 2.4110.20 ± 3.215.29 ± 2.573.54 ± 1.24

Notes: comparison among HINS, IGT, and T2DM groups, , compared with nonobesity subgroups and , compared with overweight subgroups.